Found: 8
Select item for more details and to access through your institution.
Ii-Key/HER-2/ neu(776–790) hybrid peptides induce more effective immunological responses over the native peptide in lymphocyte cultures from patients with HER-2/ neu+ tumors.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 5, p. 601, doi. 10.1007/s00262-006-0213-z
- By:
- Publication type:
- Article
Immunogenic HER-2/neu peptides as tumor vaccines.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 1, p. 85, doi. 10.1007/s00262-005-0692-3
- By:
- Publication type:
- Article
Generation of human tumor-specific CTLs in HLA-A2.1-transgenic mice using unfractionated peptides from eluates of human primary breast and ovarian tumors.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 11, p. 1027, doi. 10.1007/s00262-004-0541-9
- By:
- Publication type:
- Article
Immunobiology of HER-2/neu oncoprotein and its potential application in cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 3, p. 166, doi. 10.1007/s00262-003-0475-7
- By:
- Publication type:
- Article
HER-2/neu-derived peptide 884–899 is expressed by human breast, colorectal and pancreatic adenocarcinomas and is recognized by in-vitro-induced specific CD4<sup>+</sup> T cell clones.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 50, n. 11, p. 615, doi. 10.1007/s002620100225
- By:
- Publication type:
- Article
Effect of IL-21 on NK cells derived from different umbilical cord blood populations.
- Published in:
- International Immunology, 2006, v. 18, n. 1, p. 49, doi. 10.1093/intimm/dxh348
- By:
- Publication type:
- Article
The prognostic significance of peritumoral tertiary lymphoid structures in breast cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 11, p. 1733, doi. 10.1007/s00262-019-02407-8
- By:
- Publication type:
- Article
Serum miRNA-based distinct clusters define three groups of breast cancer patients with different clinicopathological and immune characteristics.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 1, p. 57, doi. 10.1007/s00262-018-2252-7
- By:
- Publication type:
- Article